Table 1.

Prevalence of migraine: the Genetic Epidemiology of Migraine Study

Age groupMen, prevalence per 100 (95% CI)Women, prevalence per 100 (95% CI)
Corrected*Uncorrected*Corrected*Uncorrected*
* Corrected for screen-negative patients. Uncorrected estimated by ignoring screen-negative patients.
Lifetime prevalence, y
20–245.5 (4.2–8.0)5.3 (4.2–8.1)17.9 (15.9–21.7)17.9 (15.9–21.7)
25–295.9 (4.3–9.0)5.5 (3.8–8.0)30.7 (24.8–42.0)24.9 (16.1–21.4)
30–347.7 (6.2–10.7)7.7 (6.3–10.7)27.8 (26.0–31.5)27.9 (23.0–28.5)
35–3911.0 (9.5–13.8)11.0 (9.5–13.9)39.2 (34.0–49.7)31.6 (26.1–31.1)
40–449.7 (8.5–12.0)9.7 (8.5–12.1)34.1 (28.2–45.7)25.5 (30.1–34.1)
45–4915.8 (11.7–23.7)11.9 (10.7–14.1)32.8 (26.9–44.5)24.0 (24.1–28.1)
50–5423.1 (17.0–35.0)12.0 (10.8–14.4)40.7 (30.2–61.2)23.8 (22.6–26.9)
≥5519.3 (10.6–36.4)10.1 (9.0–12.3)34.1 (27.7–46.7)22.1 (22.8–26.0)
Total13.3 (11.7–16.2)9.8 (8.5–12.3)33.0 (30.8–37.3)24.1 (23.2–27.7)
1-Year prevalence
20–243.0 (2.0–5.3)3.1 (1.9–5.3)17.0 (14.9–20.7)16.9 (14.9–20.7)
25–293.8 (2.4–6.7)3.8 (2.4–6.7)24.1 (18.3–35.6)18.4 (16.4–20.7)
30–344.4 (3.1–7.0)4.4 (3.1–7.0)21.4 (19.5–25.3)21.4 (16.4–22.2)
35–398.8 (7.4–11.5)8.1 (6.7–10.1)33.2 (27.8–43.7)25.5 (19.6–25.0)
40–446.5 (5.4–8.8)6.6 (5.4–8.8)27.5 (21.6–39.0)18.9 (24.0–28.4)
45–498.3 (7.1–10.5)8.3 (7.1–10.5)27.4 (21.4–39.1)18.6 (17.4–21.7)
50–5415.7 (10.5–25.7)8.3 (7.0–10.7)24.0 (15.9–39.8)15.5 (16.9–21.9)
≥555.6 (4.6–7.7)5.6 (4.6–7.7)20.4 (14.9–31.2)12.4 (14.2–18.1)
Total7.5 (6.8–8.9)6.5 (5.2–8.8)25.0 (23.0–28.8)18.1 (17.7–22.5)